Clinical features of 50 cases of 2019 novel coronavirus in Bandar Abbas, Iran

Hashem Jarineshin1, Fateme Saljoughi2, Hamideh Estabraghnia Babaki1

  • 1Critical Care and Pain Management Research Center, Hormozgan University of Medical Sciences, Bandar Abbas, Iran.

Insights

This study details the clinical features and outcomes of 50 coronavirus disease 2019 (COVID-19) patients. Key findings include common symptoms, laboratory abnormalities, and risk factors associated with severe illness and mortality in COVID-19.

Area of Science:

  • Infectious Diseases
  • Pulmonology
  • Critical Care Medicine

Background:

  • Limited data exists on the clinical presentation and outcomes of coronavirus disease 2019 (COVID-19).
  • Understanding COVID-19's impact is crucial for effective patient management and public health strategies.

Purpose of the Study:

  • To describe the epidemiological, demographic, clinical, laboratory, and radiological features of COVID-19 patients.
  • To compare outcomes between critically ill and non-critically ill COVID-19 patients.
  • To identify factors associated with mortality in COVID-19.

Main Methods:

  • A single-center retrospective observational study of 50 COVID-19 patients.
  • Collection and analysis of epidemiological, demographic, clinical, laboratory, radiological, and treatment data.
  • Comparison of outcomes between critically ill and non-critically ill patient groups.

Main Results:

  • The average patient age was 48.8 years, with a male predominance. Common symptoms included dry cough, fever, and dyspnea. Chronic medical illnesses were present in 56% of patients.
  • Frequent laboratory abnormalities included lymphopenia, neutrophilia, thrombocytopenia, elevated liver enzymes, creatinine, lactate dehydrogenase, ESR, and CRP. Chest CT scans often showed bilateral ground-glass opacities and consolidation.
  • 10% of patients died, with mortality higher in men and those with chronic illnesses or requiring invasive mechanical ventilation. Blood oxygen saturation differed between survivors and non-survivors.

Conclusions:

  • COVID-19 presents with a wide spectrum of signs and symptoms.
  • Laboratory findings suggest potential cellular immune deficiency, myocardial, hepatic, and kidney injury associated with COVID-19.
  • Further research is necessary to fully understand the pathogenesis of COVID-19.

Related Concept Videos

Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
79
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
70
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
447
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
291
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
564
Pericarditis II: Clinical Features and Diagnostic Tests01:19

Pericarditis II: Clinical Features and Diagnostic Tests

Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
105